{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T16:18:38Z","timestamp":1773677918908,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014382","name":"Ipsen Pharma SAS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"F. Hoffmann-La Roche Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004755","name":"EMD Serono Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004755","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001009","name":"Bristol-Myers Squibb Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023368","name":"Eisai Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck & Co Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GSK plc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.clgc.2026.102518","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:59:11Z","timestamp":1770685151000},"page":"102518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Node Positive Resected Renal Cell Carcinoma Portends a Poor Prognosis: Results From the Canadian Kidney Cancer Collaboration"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9229-7988","authenticated-orcid":false,"given":"Jesse TR","family":"Spooner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Bitcon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6418-625X","authenticated-orcid":false,"given":"Wyatt","family":"MacNevin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranjeeta","family":"Mallick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodney H.","family":"Breau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lori A.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6947-304X","authenticated-orcid":false,"given":"Simon","family":"Tanguay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Finelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas","family":"Dean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miles","family":"Mannas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmir G.","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9286-5965","authenticated-orcid":false,"given":"Luke T.","family":"Lavall\u00e9e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Baptiste","family":"Lattouf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6651-1079","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric","family":"Pouliot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9907-9112","authenticated-orcid":false,"given":"Aly-Khan A.","family":"Lalani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Heng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Bjarnason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3163-9902","authenticated-orcid":false,"given":"Naveen","family":"Basappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bimal","family":"Bhindi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla","family":"Tajzler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Rendon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.clgc.2026.102518_bib0001","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/j.ejso.2017.07.016","article-title":"European temporal trends in the use of lymph node dissection in patients with renal cancer","volume":"43","author":"Capitanio","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.clgc.2026.102518_bib0002","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1038\/s41598-021-82750-y","article-title":"Prognostic significance of pathologic nodal positivity in non-metastatic patients with renal cell carcinoma who underwent radical or partial nephrectomy","volume":"11","author":"Kim","year":"2021","journal-title":"Sci Rep"},{"issue":"20","key":"10.1016\/j.clgc.2026.102518_bib0003","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1002\/cncr.31661","article-title":"Renal cell carcinoma and pathologic nodal disease: implications for American Joint Committee on cancer staging","volume":"124","author":"Yu","year":"2018","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.clgc.2026.102518_bib0004","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.eururo.2008.09.052","article-title":"Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881","volume":"55","author":"Blom","year":"2009","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.clgc.2026.102518_bib0005","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s00345-013-1233-x","article-title":"Analysis of lymph node dissection in patients with \u2265 7-cm renal tumors","volume":"32","author":"Feuerstein","year":"2014","journal-title":"World J Urol"},{"issue":"4","key":"10.1016\/j.clgc.2026.102518_bib0006","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.eururo.2016.09.019","article-title":"Radical nephrectomy with or without lymph node dissection for nonmetastatic renal cell carcinoma: a propensity score-based analysis","volume":"71","author":"Gershman","year":"2017","journal-title":"Eur Urol"},{"issue":"13","key":"10.1016\/j.clgc.2026.102518_bib0007","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1002\/cncr.32912","article-title":"Impact of pathologic lymph node-positive renal cell carcinoma on survival in patients without metastasis: evidence in support of expanding the definition of stage IV kidney cancer","volume":"126","author":"Srivastava","year":"2020","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.clgc.2026.102518_bib0008","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.eururo.2016.12.027","article-title":"Renal cell carcinoma with isolated lymph node involvement: long-term natural history and predictors of oncologic outcomes following surgical resection","volume":"72","author":"Gershman","year":"2017","journal-title":"Eur Urol"},{"issue":"12","key":"10.1016\/j.clgc.2026.102518_bib0009","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.urolonc.2019.08.003","article-title":"The natural history of renal cell carcinoma with isolated lymph node metastases following surgical resection from 2006 to 2013","volume":"37","author":"Golijanin","year":"2019","journal-title":"Urol Oncol"},{"issue":"15","key":"10.1016\/j.clgc.2026.102518_bib0010","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa2312695","article-title":"Overall survival with adjuvant pembrolizumab in renal-cell carcinoma","volume":"390","author":"Choueiri","year":"2024","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.clgc.2026.102518_bib0011","doi-asserted-by":"crossref","first-page":"E499","DOI":"10.5489\/cuaj.6716","article-title":"Determining generalizability of the Canadian Kidney Cancer information system (CKCis) to the entire Canadian kidney cancer population","volume":"14","author":"Tajzler","year":"2020","journal-title":"Can Urol Assoc J"},{"issue":"7624","key":"10.1016\/j.clgc.2026.102518_bib0012","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"von Elm","year":"2007","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.clgc.2026.102518_bib0013","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.eururo.2018.01.005","article-title":"Predicting oncologic outcomes in renal cell carcinoma after surgery","volume":"73","author":"Leibovich","year":"2018","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.clgc.2026.102518_bib0014","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.urology.2008.02.061","article-title":"Impact of comorbidity on overall survival in patients surgically treated for renal cell carcinoma","volume":"72","author":"Berger","year":"2008","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.clgc.2026.102518_bib0015","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/cam4.2775","article-title":"Prognostic analysis of postoperative clinically nonmetastatic renal cell carcinoma","volume":"9","author":"Shao","year":"2020","journal-title":"Cancer Med"},{"issue":"5","key":"10.1016\/j.clgc.2026.102518_bib0016","doi-asserted-by":"crossref","first-page":"e968","DOI":"10.1016\/j.clgc.2019.05.011","article-title":"Lymph node density as an independent prognostic factor in node-positive renal-cell carcinoma: results from the surveillance, epidemiology, and end results program","volume":"17","author":"Liao","year":"2019","journal-title":"Clin Genitourin Cancer"},{"issue":"7","key":"10.1016\/j.clgc.2026.102518_bib0017","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/cncr.11234","article-title":"Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials","volume":"97","author":"Leibovich","year":"2003","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.clgc.2026.102518_bib0018","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s00345-023-04413-z","article-title":"Neglected lymph nodal metastases in patients with renal cancer: when to extend the anatomical template of lymph node dissection during nephrectomy","volume":"41","author":"Rosiello","year":"2023","journal-title":"World J Urol"},{"issue":"5","key":"10.1016\/j.clgc.2026.102518_bib0019","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.juro.2017.11.114","article-title":"Radical nephrectomy with or without lymph node dissection for high risk nonmetastatic renal cell carcinoma: a multi-institutional analysis","volume":"199","author":"Gershman","year":"2018","journal-title":"J Urol"},{"issue":"11-12","key":"10.1016\/j.clgc.2026.102518_bib0020","doi-asserted-by":"crossref","first-page":"397","DOI":"10.5489\/cuaj.2848","article-title":"Clinical outcomes following laparoscopic management of pT3 renal masses: a large, multi-institutional cohort","volume":"9","author":"Nayak","year":"2015","journal-title":"Can Urol Assoc J"},{"issue":"6","key":"10.1016\/j.clgc.2026.102518_bib0021","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.eururo.2006.12.015","article-title":"Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival","volume":"51","author":"Karakiewicz","year":"2007","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.clgc.2026.102518_bib0022","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/ijc.32578","article-title":"Long survival of patients with metastatic clear cell renal cell carcinoma. Results of real life study of 344 patients","volume":"146","author":"Voog","year":"2020","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.clgc.2026.102518_bib0023","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.euo.2023.11.016","article-title":"Real-world assessment of clinical outcomes in patients with metastatic renal cell carcinoma with or without sarcomatoid features treated with first-line systemic therapies","volume":"7","author":"Sawaya","year":"2024","journal-title":"Eur Urol Oncol"},{"issue":"8","key":"10.1016\/j.clgc.2026.102518_bib0024","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.1245\/s10434-024-15431-5","article-title":"Sarcomatoid dedifferentiation as a predictor of cancer-specific mortality in surgically treated localized renal cell carcinoma","volume":"31","author":"Incesu","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.clgc.2026.102518_bib0025","first-page":"327","article-title":"Prognostic significance of sarcomatoid features in metastatic renal cell carcinoma treated with cytoreductive nephrectomy and targeted therapy","volume":"10","author":"Cortese","year":"2022","journal-title":"Am J Clin Exp Urol"},{"issue":"5","key":"10.1016\/j.clgc.2026.102518_bib0026","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/bju.16609","article-title":"Is there a minimum percentage of sarcomatoid component required to affect outcomes of localised renal cell carcinoma?","volume":"135","author":"Soytas","year":"2025","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.clgc.2026.102518_bib0027","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.juro.2008.11.098","article-title":"Presence of tumor necrosis is not a significant predictor of survival in clear cell renal cell carcinoma: higher prognostic accuracy of extent based rather than presence\/absence classification","volume":"181","author":"Klatte","year":"2009","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.clgc.2026.102518_bib0028","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.juro.2009.11.010","article-title":"Percent microscopic tumor necrosis and survival after curative surgery for renal cell carcinoma","volume":"183","author":"Katz","year":"2010","journal-title":"J Urol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767326000182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767326000182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T14:53:19Z","timestamp":1773672799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767326000182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1558767326000182"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2026.102518","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Node Positive Resected Renal Cell Carcinoma Portends a Poor Prognosis: Results From the Canadian Kidney Cancer Collaboration","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2026.102518","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102518"}}